Medical and Pharmaceutical Hong Kong lung cancer survivor advocates for AI-powered screening measures Artificial intelligence has the power to cut healthcare costs associated with lung cancer screening in half, he highlighted Rowan DunneJuly 28, 2025
Crypto/Blockchain Liminatus Pharma shares spike 26% on Digital Asset focused capital raise plans The engagement builds upon Liminatus’s previously announced review of a blockchain-integrated treasury strategy Joseph MortonJuly 24, 2025
Medical and Pharmaceutical Lung cancer survivor & spouse use wood ribbons to promote disease awareness The White Ribbon Project aims to draw attention to how anyone can be diagnosed with the condition Rowan DunneJuly 24, 2025
Medical and Pharmaceutical bioAffinity Technologies obtains Canadian patent for lung cancer spit test The CyPath Lung screening tool is also patented in China, Australia and Japan Rowan DunneJuly 22, 2025
Medical and Pharmaceutical Medpace Holdings stock just popped by 50%, but why? Medpace delivered a standout Q2, with revenue rising 14.2 per cent year-over-year to USD$603.3 million Joseph MortonJuly 22, 2025
Medical and Pharmaceutical Whoop on the FDA hot seat for not following marketing rules The FDA maintains that blood pressure estimation is not a low-risk function Joseph MortonJuly 21, 2025
Medical and Pharmaceutical U.S. tariffs on Chinese medical devices threaten global supply chains Donald Trump increased tariffs on Chinese goods several times during his presidency Joseph MortonJuly 21, 2025
Health & Wellness Oxford Biodynamics surges after Pfizer trial backs blood-based cancer test The platform makes it possible to track disease progression and therapy effectiveness in real-time Joseph MortonJuly 18, 2025
Medical and Pharmaceutical American researcher anticipates robust growth for e-nose market Market.US is one of multiple that believe the breath analysis industry will be expanding significantly Rowan DunneJuly 17, 2025
Health & Wellness BeOne Medicines gets positive stock bump on RBC Capital upgrade Analysts see strong upside potential in BeOne’s move into solid tumours Joseph MortonJuly 16, 2025